S&P ASX All Technology

US Dollar vs AUD

Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Get Started

GTBP GT Biopharma Inc

2.13

0.02 (0.95%)

After Hours

Last Updated: 08:22:36

Delayed by 15 minutes

Form 3 - Initial statement of beneficial ownership of securities

GT Biopharma (NASDAQ:GTBP)
Historical Stock Chart
From Jan 2025 to Feb 2025

Click Here for more GT Biopharma Charts.

GT Biopharma (NASDAQ:GTBP)
Historical Stock Chart
From Feb 2024 to Feb 2025

Click Here for more GT Biopharma Charts.

GT Biopharma Inc News

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Saturday 8 February 2025 (2 weeks ago) • Edgar (US Regulatory)

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Tuesday 28 January 2025 (3 weeks ago) • Edgar (US Regulatory)

Form 8-K - Current report
Monday 27 January 2025 (3 weeks ago) • Edgar (US Regulatory)

Form S-1 - General form for registration of securities under the Securities Act of 1933
Tuesday 24 December 2024 (2 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Thursday 28 November 2024 (3 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Friday 22 November 2024 (3 months ago) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Friday 15 November 2024 (3 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 22 October 2024 (4 months ago) • Edgar (US Regulatory)

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Friday 18 October 2024 (4 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Tuesday 17 September 2024 (5 months ago) • Edgar (US Regulatory)

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Tuesday 18 June 2024 (8 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Saturday 8 June 2024 (8 months ago) • Edgar (US Regulatory)

More GT Biopharma Inc News Articles

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions